MDT · Categories · Upgrades
MDT - Analyst upgrades
Medtronic plc. (MDT) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for MDT
- Medtronic upgraded by BTIG Research with a new price targetBTIG Research upgraded Medtronic from Neutral to Buy and set a new price target of $90.00
- Medtronic upgraded by Needham with a new price targetNeedham upgraded Medtronic from Hold to Buy and set a new price target of $121.00
- Medtronic upgraded by William BlairWilliam Blair upgraded Medtronic from Mkt Perform to Outperform
- Medtronic upgraded by Goldman with a new price targetGoldman upgraded Medtronic from Sell to Neutral and set a new price target of $111.00
- Medtronic upgraded by Wolfe ResearchWolfe Research upgraded Medtronic from Underperform to Peer Perform
- Medtronic upgraded by Citigroup with a new price targetCitigroup upgraded Medtronic from Neutral to Buy and set a new price target of $107.00 from $92.00 previously
- Medtronic upgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts upgraded Medtronic from Sector Perform to Outperform and set a new price target of $105.00 from $98.00 previously
- Medtronic upgraded by UBS with a new price targetUBS upgraded Medtronic from Sell to Neutral and set a new price target of $90.00 from $76.00 previously
- Medtronic upgraded by Morgan Stanley with a new price targetMorgan Stanley upgraded Medtronic from Equal-Weight to Overweight and set a new price target of $104.00
- Medtronic upgraded by Wells Fargo with a new price targetWells Fargo upgraded Medtronic from Equal Weight to Overweight and set a new price target of $100.00 from $77.00 previously